DOCSLIB.ORG

Transgelin Is a Novel Marker of Smooth Muscle Differentiation That Improves Diagnostic Accuracy of Leiomyosarcomas

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Transgelin Is a Novel Marker of Smooth Muscle Differentiation That Improves Diagnostic Accuracy of Leiomyosarcomas Modern Pathology (2013) 26, 502–510 502 & 2013 USCAP, Inc All rights reserved 0893-3952/13 $32.00 Transgelin is a novel marker of smooth muscle differentiation that improves diagnostic accuracy of leiomyosarcomas: a comparative immunohistochemical reappraisal of myogenic markers in 900 soft tissue tumors Yves-Marie Robin1, Nicolas Penel2,3, Gae¨lle Pe´rot4,5, Agnes Neuville4,5,6, Vale´rie Ve´lasco4,5, Dominique Ranche`re-Vince7, Philippe Terrier8 and Jean-Michel Coindre4,5,6 1Department of Biology, Unit of Morphological and Molecular Pathology, Centre Oscar Lambret, Lille Cedex, France; 2Department of General Oncology, Centre Oscar Lambret, Lille Cedex, France; 3Research Unit (EA 2694), Medical School University, Lille-Nord-de-France University, Lille Cedex, France; 4Department of Pathology, Institut Bergonie´, Bordeaux Cedex, France; 5INSERM U916, Institut Bergonie´, Bordeaux, France; 6Laboratory of Pathology, Universite´ Victor Segalen Bordeaux 2, Bordeaux, France; 7Department of Patholoy, Centre Le´on Be´rard, Lyon, France and 8Department of Pathology, Institut Gustave Roussy, Villejuif, France Immunohistochemical use of myogenic markers serves to define smooth or skeletal muscle differentiation in soft tissue tumors. Establishing smooth muscle differentiation in malignant lesions can be challenging in some cases. We immunohistochemically examined 900 soft tissue tumors selected from the French Sarcoma Group’s archived tissue collection, which contains a large number of leiomyosarcomas. The four most widely used smooth muscle diagnostic markers were evaluated (smooth muscle actin, desmin, h-caldesmon and calponin), and compared with a novel marker, transgelin. The diagnostic performance of each marker was statistically assessed in terms of sensitivity (Se), specificity (Sp), positive predictive value (PPV), negative predictive value (NPV) and accuracy (A), in leiomyosarcomas versus all other sarcomas including gastrointestinal stromal tumors (GIST), and second in leiomyosarcomas versus specific tumor types. In leiomyosarcomas versus all other sarcomas including GIST, transgelin emerged as the best diagnostic marker (Se: 83%, Sp: 82%, PPV: 67%, NPV: 92%, A: 83%), compared with smooth muscle actin (Se: 75%, Sp: 83, PPV: 66%, NPV: 89%, A: 81%), desmin (Se: 45%, Sp: 88%, PPV: 62%, NPV: 79%, A: 75%), h-caldesmon (Se: 50%, Sp: 90%, PPV: 67%, NPV: 81%, A: 78%) and calponin (Se: 76%, Sp: 70, PPV: 52%, NPV: 87%, A: 71%). In leiomyosarcomas compared with other specific tumor types such as undifferentiated pleomorphic sarcoma and myxofibrosarcoma, the accuracy for transgelin varied from 80 to 87% whereas it was lower for all other markers (between 51 and 80%). These results indicate that transgelin could be used in practice as an additional marker useful for decision making, especially in those tumors with incomplete immunophenotypes. Modern Pathology (2013) 26, 502–510; doi:10.1038/modpathol.2012.192; published online 23 November 2012 Keywords: immunohistochemistry; smooth muscle differentiation; transgelin; tissue microarray Leiomyosarcoma is one of the most frequent sarco- that soft tissue sarcomas showing a myoid differe- ma histotypes and represents about 15% of all soft ntiation, most often a smooth muscle differentiation, tissue sarcomas.1 The diagnosis of leiomyosarcoma are more aggressive than those with no myoid is clinically important because it has been reported differentiation.2,3 However, the distinction between a poorly differentiated leiomyosarcoma and an undifferentiated spindle cell or pleomorphic Correspondence: Professor J-M Coindre, MD, Department of sarcoma based on morphological features only is Pathology and INSERM U916, Institut Bergonie´, Bordeaux, France. E-mail: [email protected] often difficult and difficult to reproduce. In this Received 11 June 2012; revised 26 September 2012; accepted 26 situation, immunohistochemistry is very helpful. September 2012; published online 23 November 2012 Although myogenin and MyoD1, myogenic www.modernpathology.org Transgelin in mesenchymal tumors Y-M Robin et al 503 transcriptional regulatory proteins, are considered comas, 10 embryonal rhabdomyosarcomas, 8 Ewing sensitive and specific markers for rhabdomyo- sarcomas, 6 soft tissue osteosarcomas, 6 clear cell sarcomas,4 there is no sensitive and specific sarcomas, 5 schwannomas, 5 leiomyomas, 5 angio- single marker for identifying a smooth muscle mas, 3 myxomas, 3 angiosarcomas, 3 soft part differentiation. Markers regularly used for the alveolar sarcomas, 3 extra-skeletal myxoid chondro- diagnosis of smooth muscle tumors are desmin, sarcomas, 2 desmoplastic small round cell tumors, an intermediate filament and smooth muscle actin, 2 neurofibromas, 2 perineurinomas, 1 sclerosing a thin filament,5 along with calponin and fibrosarcoma, 1 malignant peripheral nerve sheath h-caldesmon, both involved in smooth muscle tumor, 1 giant cell tumor of the tendon, 1 myofibro- contraction.6,7 Smooth muscle actin and desmin blastoma and 1 granular cell tumor. Diagnosis of are generally expressed in many different types of leiomyosarcoma was based on criteria derived from skeletal muscle, smooth muscle, myofibroblastic Fletcher et al’s2 and Deyrup et al’s3 reports: a tumor and myoepithelial tumors, as well as in other that at least focally showed the presence lesions. Therefore, rigorous criteria should be used of eosinophilic spindle cells with vesicular blunt- to interpret positive myogenic markers in the ended nuclei arranged in a fascicular pattern. Such diagnosis of leiomyosarcomas.5,8,9 H-caldesmon is foci always accounted for at least 5 to 10% of the reputedly specific to smooth muscle differentiation surface examined. Tumors with these characteristics but lacks sensitivity (Se).6,7 Calponin is quite useful were also required to show extensive positivity for to assess smooth muscle differentiation although it smooth muscle actin or calponin, or focal and strong is probably more frequently used to detect positivity for desmin or h-caldesmon. The leiomyo- myoepithelial or myofibroblast lineage.6,7 A novel sarcoma differentiation level has been evaluated marker, transgelin, a 22 kDa actin-binding protein of according to the differentiation score used for the the calponin family, also correlates with smooth French sarcomas grading system, which is based on muscle differentiation.10 The promoter of the gene histological aspects only.12 In all, 65 cases out of 184 is the target of the transcriptional activator serum (35%) were defined as poorly differentiated (differen- response factor of which myocardin acts as a tiation score of 3) and therefore needed immunohisto- cofactor.11 In an unpublished study, Aurias et al chemistry to obtain a diagnosis of leiomyosarcoma. (Institut Curie, France), isolated target genes of Undifferentiated pleomorphic sarcomas were defined myocardin through gene expression profiling using as pleomorphic/spindle cell sarcoma with sarcoma cell lines and found that transgelin was one no evidence of a specific line of differentiation.2,13 of the most represented in leiomyosarcomatous All tumor slides were reviewed in full sections for differentiation. In this study, we aimed to establish diagnosis confirmation before tumor selection. whether or not transgelin is a useful addition to the other better-known smooth muscle differentiation Tissue Micro-Array markers, in leiomyosarcomas versus all other sarcomas including gastrointestinal stromal tumors All samples were paraffin embedded and formalin (GIST), and secondly in leiomyosarcomas versus fixed. A total of 816 tumors were examined in tissue specific tumor types. The diagnostic performance micro-array blocks with three spots of 1 mm per of transgelin was compared with that of smooth sample. The rest were examined in full sections. muscle actin, desmin, h-caldesmon and calponin in In the dermatofibrosarcoma protuberans subgroup, a large series of benign and malignant mesenchymal 15 tumors were examined in tissue micro-array with lesions irrespective of the line of differentiation or all markers, and 30 in whole sections with transge- anatomic site. lin alone. Immunohistochemistry Materials and methods Slides of 4-um-thick tissue sections were incubated Tumor Selection at room temperature in standard CC1 buffer (Venta- na), revealed with ‘Ultra View’ Universal DAB kit Nine hundred soft tissue tumors were selected and stained with Hematoxylin ReaDi solution from the French Sarcoma Group’s archived paraf- (Ventana). They were treated on automate VENTA- fin-embedded tissue collection: 184 leiomyosarco- NA-Benchmark-XT with the following antibodies: mas, 143 undifferentiated pleomorphic sarcomas, 80 smooth muscle actin (clone: 1A4; pre-treatment: desmoid tumors, 68 myxofibrosarcomas, 65 dedif- CC1; prediluted; source: Ventana), desmin (clone ferentiated liposarcomas, 60 synovial sarcomas, 50 D33, pre-treatment: CC1 ct; dilution: 1/50, source: GIST, 45 dermatofibrosarcoma protuberans, 36 spin- DAKO), caldesmon (clone Hcd, pre-treatment: CC1 dle cell/pleomophic lipomas, 26 nodular fasciitis, std; dilution: 1/50; source: DAKO), calponin (clone 19 pleomophic liposarcoma, 13 well-differentiated CALP; pre-treatment: CC1 std, dilution: 1/100, lipoma-like liposarcomas, 12 pleomorphic rhabdo- source: Biogenex) and transgelin (clone SM22 myosarcomas, 11 myxoid/round cell liposarcomas, ALPHA; pre-treatment: none; dilution: 1/500, 10 adult fibrosarcomas, 10 alveolar rhabdomyosar- source: Abcam). Modern Pathology (2013) 26, 502–510 Transgelin in mesenchymal
Load more

Recommended publications
  • Nodular Fasciitis of the Pectoralis Muscle in a 54-Year-Old Woman
    ACS Case Reviews in Surgery Vol. 2, No. 3 Nodular Fasciitis of the Pectoralis Muscle in a 54-Year-Old Woman AUTHORS: CORRESPONDENCE AUTHOR: AUTHOR AFFILIATIONS: Christopher D. Kannera; Divya Sharma, MDb; Dr. Jaime D Lewis a. Medical Student, University of Cincinnati College Jaime D Lewis, MD, FACSc UC Health Women’s Center of Medicine, Cincinnati, Ohio 7675 Wellness Way b. Department of Pathology and Laboratory West Chester, Ohio 45069 Medicine, University of Cincinnati College of Phone: (513) 584-8900 Medicine, Cincinnati, Ohio Email: [email protected] c. Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio Background A 54-year-old woman presented with a breast mass found to be nodular fasciitis of the right pectoralis muscle. Summary A 54-year-old woman presented to a breast surgeon for evaluation of a painful right breast mass. Initial mammography was unrevealing. Ultrasound revealed a right pectoral mass extending into the soft tissue of the breast. Core needle biopsy specimen revealed features suggestive of low grade sarcoma. Findings on computed tomography (CT) and magnetic resonance imaging (MRI) were nonspecific and wide local excision was subsequently performed. Pathologic characteristics were consistent with nodular fasciitis. This benign proliferation of fibroblasts and myofibroblasts frequently raises concern for malignant neoplasms due to its rapid, infiltrative growth, and nonspecific imaging characteristics. Thus, it is often identified by its characteristic features on surgical pathology following excision. On rare occasions when it is managed with surveillance, nodular fasciitis frequently demonstrates spontaneous regression. Conclusion Nodular fasciitis is a benign growth with a tendency for spontaneous regression, which exhibits clinical features that often invoke suspicion of malignancy.
    [Show full text]
  • Soft Tissue Cytopathology: a Practical Approach Liron Pantanowitz, MD
    4/1/2020 Soft Tissue Cytopathology: A Practical Approach Liron Pantanowitz, MD Department of Pathology University of Pittsburgh Medical Center [email protected] What does the clinician want to know? • Is the lesion of mesenchymal origin or not? • Is it begin or malignant? • If it is malignant: – Is it a small round cell tumor & if so what type? – Is this soft tissue neoplasm of low or high‐grade? Practical diagnostic categories used in soft tissue cytopathology 1 4/1/2020 Practical approach to interpret FNA of soft tissue lesions involves: 1. Predominant cell type present 2. Background pattern recognition Cell Type Stroma • Lipomatous • Myxoid • Spindle cells • Other • Giant cells • Round cells • Epithelioid • Pleomorphic Lipomatous Spindle cell Small round cell Fibrolipoma Leiomyosarcoma Ewing sarcoma Myxoid Epithelioid Pleomorphic Myxoid sarcoma Clear cell sarcoma Pleomorphic sarcoma 2 4/1/2020 CASE #1 • 45yr Man • Thigh mass (fatty) • CNB with TP (DQ stain) DQ Mag 20x ALT –Floret cells 3 4/1/2020 Adipocytic Lesions • Lipoma ‐ most common soft tissue neoplasm • Liposarcoma ‐ most common adult soft tissue sarcoma • Benign features: – Large, univacuolated adipocytes of uniform size – Small, bland nuclei without atypia • Malignant features: – Lipoblasts, pleomorphic giant cells or round cells – Vascular myxoid stroma • Pitfalls: Lipophages & pseudo‐lipoblasts • Fat easily destroyed (oil globules) & lost with preparation Lipoma & Variants . Angiolipoma (prominent vessels) . Myolipoma (smooth muscle) . Angiomyolipoma (vessels + smooth muscle) . Myelolipoma (hematopoietic elements) . Chondroid lipoma (chondromyxoid matrix) . Spindle cell lipoma (CD34+ spindle cells) . Pleomorphic lipoma . Intramuscular lipoma Lipoma 4 4/1/2020 Angiolipoma Myelolipoma Lipoblasts • Typically multivacuolated • Can be monovacuolated • Hyperchromatic nuclei • Irregular (scalloped) nuclei • Nucleoli not typically seen 5 4/1/2020 WD liposarcoma Layfield et al.
    [Show full text]
  • Appendix 4 WHO Classification of Soft Tissue Tumours17
    S3.02 The histological type and subtype of the tumour must be documented wherever possible. CS3.02a Accepting the limitations of sampling and with the use of diagnostic common sense, tumour type should be assigned according to the WHO system 17, wherever possible. (See Appendix 4 for full list). CS3.02b If precise tumour typing is not possible, generic descriptions to describe the tumour may be useful (eg myxoid, pleomorphic, spindle cell, round cell etc), together with the growth pattern (eg fascicular, sheet-like, storiform etc). (See G3.01). CS3.02c If the reporting pathologist is unfamiliar or lacks confidence with the myriad possible diagnoses, then at this point a decision to send the case away without delay for an expert opinion would be the most sensible option. Referral to the pathologist at the nearest Regional Sarcoma Service would be appropriate in the first instance. Further International Pathology Review may then be obtained by the treating Regional Sarcoma Multidisciplinary Team if required. Adequate review will require submission of full clinical and imaging information as well as histological sections and paraffin block material. Appendix 4 WHO classification of soft tissue tumours17 ADIPOCYTIC TUMOURS Benign Lipoma 8850/0* Lipomatosis 8850/0 Lipomatosis of nerve 8850/0 Lipoblastoma / Lipoblastomatosis 8881/0 Angiolipoma 8861/0 Myolipoma 8890/0 Chondroid lipoma 8862/0 Extrarenal angiomyolipoma 8860/0 Extra-adrenal myelolipoma 8870/0 Spindle cell/ 8857/0 Pleomorphic lipoma 8854/0 Hibernoma 8880/0 Intermediate (locally
    [Show full text]
  • Transgelin Interacts with PARP1 and Affects Rho Signaling Pathway in Human Colon Cancer Cells
    Transgelin interacts with PARP1 and affects Rho signaling pathway in human colon cancer cells Zhen-xian Lew Guangzhou Concord Cancer Center Hui-min Zhou First Aliated Hospital of Guangdong Pharmaceutical College Yuan-yuan Fang Tongling Peoples's Hospital Zhen Ye Sun Yat-sen Memorial Hospital Wa Zhong Sun Yat-sen Memorial Hospital Xin-yi Yang The Seventh Aliated Hospital Sun Yat-sen University Zhong Yu Sun Yat-sen Memorial Hospital of Sun Yat-sen University Dan-yu Chen Sun Yat-sen Memorial Hospital Si-min Luo Sun Yat-sen Memorial Hospital Li-fei Chen Sun Yat-sen Memorial Hospital Ying Lin ( [email protected] ) Sun Yat-sen Memorial Hospital https://orcid.org/0000-0003-2416-2154 Primary research Keywords: Transgelin, PARP1, Colon Cancer, Rho Signaling, Bioinformatics Posted Date: July 1st, 2020 DOI: https://doi.org/10.21203/rs.3.rs-16964/v2 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/22 Version of Record: A version of this preprint was published on August 3rd, 2020. See the published version at https://doi.org/10.1186/s12935-020-01461-y. Page 2/22 Abstract Background: Transgelin, an actin-binding protein, is associated with the cytoskeleton remodeling. Our previous studies found that transgelin was up-regulated in node-positive colorectal cancer versus in node- negative disease. Over-expression of TAGLN affected the expression of 256 downstream transcripts and increased the metastatic potential of colon cancer cells in vitro and in vivo. This study aims to explore the mechanisms that transgelin participates in the metastasis of colon cancer cells.
    [Show full text]
  • The 2020 WHO Classification of Soft Tissue Tumours: News and Perspectives
    PATHOLOGICA 2021;113:70-84; DOI: 10.32074/1591-951X-213 Review The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives Marta Sbaraglia1, Elena Bellan1, Angelo P. Dei Tos1,2 1 Department of Pathology, Azienda Ospedale Università Padova, Padova, Italy; 2 Department of Medicine, University of Padua School of Medicine, Padua, Italy Summary Mesenchymal tumours represent one of the most challenging field of diagnostic pathol- ogy and refinement of classification schemes plays a key role in improving the quality of pathologic diagnosis and, as a consequence, of therapeutic options. The recent publica- tion of the new WHO classification of Soft Tissue Tumours and Bone represents a major step toward improved standardization of diagnosis. Importantly, the 2020 WHO classi- fication has been opened to expert clinicians that have further contributed to underline the key value of pathologic diagnosis as a rationale for proper treatment. Several rel- evant advances have been introduced. In the attempt to improve the prediction of clinical behaviour of solitary fibrous tumour, a risk assessment scheme has been implemented. NTRK-rearranged soft tissue tumours are now listed as an “emerging entity” also in con- sideration of the recent therapeutic developments in terms of NTRK inhibition. This deci- sion has been source of a passionate debate regarding the definition of “tumour entity” as well as the consequences of a “pathology agnostic” approach to precision oncology. In consideration of their distinct clinicopathologic features, undifferentiated round cell sarcomas are now kept separate from Ewing sarcoma and subclassified, according to the underlying gene rearrangements, into three main subgroups (CIC, BCLR and not Received: October 14, 2020 ETS fused sarcomas) Importantly, In order to avoid potential confusion, tumour entities Accepted: October 19, 2020 such as gastrointestinal stroma tumours are addressed homogenously across the dif- Published online: November 3, 2020 ferent WHO fascicles.
    [Show full text]
  • 2016 Essentials of Dermatopathology Slide Library Handout Book
    2016 Essentials of Dermatopathology Slide Library Handout Book April 8-10, 2016 JW Marriott Houston Downtown Houston, TX USA CASE #01 -- SLIDE #01 Diagnosis: Nodular fasciitis Case Summary: 12 year old male with a rapidly growing temple mass. Present for 4 weeks. Nodular fasciitis is a self-limited pseudosarcomatous proliferation that may cause clinical alarm due to its rapid growth. It is most common in young adults but occurs across a wide age range. This lesion is typically 3-5 cm and composed of bland fibroblasts and myofibroblasts without significant cytologic atypia arranged in a loose storiform pattern with areas of extravasated red blood cells. Mitoses may be numerous, but atypical mitotic figures are absent. Nodular fasciitis is a benign process, and recurrence is very rare (1%). Recent work has shown that the MYH9-USP6 gene fusion is present in approximately 90% of cases, and molecular techniques to show USP6 gene rearrangement may be a helpful ancillary tool in difficult cases or on small biopsy samples. Weiss SW, Goldblum JR. Enzinger and Weiss’s Soft Tissue Tumors, 5th edition. Mosby Elsevier. 2008. Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, Ye Y, Lau AW, Wang X, Oliveira AM. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest. 2011 Oct;91(10):1427-33. Amary MF, Ye H, Berisha F, Tirabosco R, Presneau N, Flanagan AM. Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool. Virchows Arch. 2013 Jul;463(1):97-8. CONTRIBUTED BY KAREN FRITCHIE, MD 1 CASE #02 -- SLIDE #02 Diagnosis: Cellular fibrous histiocytoma Case Summary: 12 year old female with wrist mass.
    [Show full text]
  • Differential Expression of Drosophila Transgelins Throughout Development
    fcell-09-648568 July 6, 2021 Time: 18:30 # 1 ORIGINAL RESEARCH published: 12 July 2021 doi: 10.3389/fcell.2021.648568 Differential Expression of Drosophila Transgelins Throughout Development Katerina M. Vakaloglou1†, Maria Mouratidou1†, Athina Keramidioti1,2 and Christos G. Zervas1* 1 Center of Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece, 2 Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece Transgelins are a conserved family of actin-binding proteins involved in cytoskeletal remodeling, cell contractility, and cell shape. In both mammals and Drosophila, three genes encode transgelin proteins. Transgelins exhibit a broad and overlapping expression pattern, which has obscured the precise identification of their role in development. Here, we report the first systematic developmental analysis of all Drosophila transgelin proteins, namely, Mp20, CG5023, and Chd64 in the Edited by: living organism. Drosophila transgelins display overall higher sequence identity with Lei-Miao Yin, mammalian TAGLN-3 and TAGLN-2 than with TAGLN. Detailed examination in different Shanghai University of Traditional Chinese Medicine, China developmental stages revealed that Mp20 and CG5023 are predominantly expressed in Reviewed by: mesodermal tissues with the onset of myogenesis and accumulate in the cytoplasm Cedric Soler, of all somatic muscles and heart in the late embryo. Notably, at postembryonic Clermont Université, France Simone Diestel, developmental stages, Mp20 and CG5023 are detected in the gut’s circumferential University of Bonn, Germany muscles with distinct subcellular localization: Z-lines for Mp20 and sarcomere and Rajesh Gunage, nucleus for CG5023. Only CG5023 is strongly detected in the adult fly in the abdominal, Boston Children’s Hospital, United States leg, and synchronous thoracic muscles.
    [Show full text]
  • KIF23 Enhances Cell Proliferation in Pancreatic Ductal Adenocarcinoma and Is a Potent Therapeutic Target
    1394 Original Article Page 1 of 15 KIF23 enhances cell proliferation in pancreatic ductal adenocarcinoma and is a potent therapeutic target Chun-Tao Gao1#, Jin Ren2#, Jie Yu1,3#, Sheng-Nan Li1, Xiao-Fan Guo1, Yi-Zhang Zhou1 1Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China; 2Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Taiyuan, China; 3The First Hospital of Shanxi Medical University, Taiyuan, China Contributions: (I) Conception and design: CT Gao, J Ren; (II) Administrative support: CT Gao; (III) Provision of study materials or patients: J Yu; (IV) Collection and assembly of data: J Ren, SN Li, YZ Zhou; (V) Data analysis and interpretation: XF Guo, J Ren; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. #These authors contributed equally to this work. Correspondence to: Chun-Tao Gao. Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Huan-hu-xi Road, He-xi District, Tianjin 300060, China. Email: [email protected]. Background: In recent research, high expression of kinesin family member 23 (KIF23), one of the kinesin motor proteins involved in the regulation of cytokinesis, has been shown to be related to poor prognosis in glioma and paclitaxel-resistant gastric cancer, as a results of the enhancement of proliferation, migration, and invasion. In this study, we analyzed the role of KIF23 in the progression of pancreatic ductal adenocarcinoma.
    [Show full text]
  • International Journal of Clinical & Experimental Otolaryngology (IJCEO) ISSN 2572-732X Angioleiomyoma of Nasal Septum: Case
    OPEN ACCESS http://scidoc.org/IJCEO.php International Journal of Clinical & Experimental Otolaryngology (IJCEO) ISSN 2572-732X Angioleiomyoma of Nasal Septum: Case Report and Literature Review Case Report Varun V. Varadarajan*, Justice JM Department of Otolaryngology, University of Florida, Gainesville, FL, USA. Abstract Introduction: Angioleiomyoma is a benign soft tissue tumor of smooth muscle origin with a vascular component and is an uncommon form of leiomyoma. Angioleiomyoma presenting in the nasal cavity is exceedingly rare and there are 68 re- ported cases in the literature worldwide. We present a case of angioleiomyoma of the nasal septum and review its diagnosis and treatment. Study Design: Case report and Literature Review. Methods: The medical records of a 69-year-old patient with an angioleiomyoma of the nasal septum were reviewed. The PubMed database was searched for literature describing anglioleiomyoma of the nasal cavity using the key words “angioleio- myoma” with “nasal cavity,” “nasal septum,” “nose,” or “sinus.” Results: A 69-year-old female patient presented with progressive right-sided nasal obstruction and epistaxis. Office ex- amination revealed stigmata of recent bleeding and nasal endoscopy revealed a mass arising from the right nasal septum. Computerized tomography with intravenous contrast revealed a 1.3 x 1.1 cm heterogeneously enhancing vascular lesion arising from the right nasal septum. The patient was taken to the operating room for endoscopic resection. Conclusion: Angioleiomyoma of the nasal septum is a rare and challenging clinical diagnosis that requires detailed histo- pathologic examination. Literature review suggests a female predilection with possible hormonal influence. Keywords: Rhinology; Angioleiomyoma; Nose Neoplasms. Introduction Otolaryngology clinic with the chief complaints of progressive right-sided nasal obstruction and epistaxis for one year in Angioleiomyoma is a benign soft tissue tumor of smooth muscle duration.
    [Show full text]
  • Angioleiomyoma of the Sinonasal Tract: Analysis of 16 Cases and Review of the Literature
    Head and Neck Pathol (2015) 9:463–473 DOI 10.1007/s12105-015-0636-y ORIGINAL PAPER Angioleiomyoma of the Sinonasal Tract: Analysis of 16 Cases and Review of the Literature 1 2 3 2 Abbas Agaimy • Michael Michal • Lester D. R. Thompson • Michal Michal Received: 7 April 2015 / Accepted: 30 May 2015 / Published online: 6 June 2015 Ó Springer Science+Business Media New York 2015 Abstract Angioleiomyoma (ALM; synonyms: angiomy- The covering mucosa was ulcerated in 6 cases and showed oma, vascular leiomyoma) is an uncommon benign tumor squamous metaplasia in one case. There were no recur- of skin and subcutaneous tissue. Most arise in the rences after local excision. Submucosal sinonasal ALMs extremities (90 %). Head and neck ALMs are uncommon are rare benign tumors similar to their reported cutaneous (*10 % of all ALMs) and those arising beneath the counterparts with frequent adipocytic differentiation. They sinonasal tract mucosa are very rare (\1 %) with 38 cases should be distinguished from renal-type angiomyolipoma. reported so far. We herein analyzed 16 cases identified Simple excision is curative. from our routine and consultation files. Patients included seven females and nine males aged 25–82 years (mean 58; Keywords Angioleiomyoma Á Sinonasal tract Á median 62). Symptoms were intermittent nasal obstruction, Angiomyolipoma Á Vascular leiomyoma Á Angiomyoma Á sinusitis, recurrent epistaxis, and a slow-growing mass. PEComa Á Nasal Fifteen lesions originated within different regions of the nasal cavity and one lesion was detected incidentally in an ethmoid sinus sample. Size range was 6–25 mm (mean 11). Introduction Histologically, all lesions were well circumscribed but non- encapsulated and most (12/16) were of the compact solid Mesenchymal tumors of the sinonasal tract are rare.
    [Show full text]
  • Polyclonal Antibody to Transgelin (TAGLN) (C-Term) - Aff - Purified
    OriGene Technologies, Inc. OriGene Technologies GmbH 9620 Medical Center Drive, Ste 200 Schillerstr. 5 Rockville, MD 20850 32052 Herford UNITED STATES GERMANY Phone: +1-888-267-4436 Phone: +49-5221-34606-0 Fax: +1-301-340-8606 Fax: +49-5221-34606-11 [email protected] [email protected] AP16212PU-N Polyclonal Antibody to Transgelin (TAGLN) (C-term) - Aff - Purified Alternate names: 22 kDa actin-binding protein, SM22, Smooth muscle protein 22-alpha, WS3-10 Quantity: 0.1 mg Concentration: 0.5 mg/ml Background: TAGLN is a transformation and shape-change sensitive actin cross-linking/gelling protein found in fibroblasts and smooth muscle. Its expression is down-regulated in many cell lines, and this down-regulation may be an early and sensitive marker for the onset of transformation. A functional role of this protein is unclear. Uniprot ID: Q01995 NCBI: NP_003177.2 GeneID: 6876 Host: Goat Immunogen: Peptide with sequence from the C-Terminus of the protein sequence according to NP_003177.2. Genename: TAGLN AA Sequence: C-MTGYGRPRQIIS Remarks: NP_003177.2 and NP_001001522.1 represent identical protein. Format: State: Liquid purified Ig fraction Purification: Ammonium Sulphate Precipitation followed by Antigen Affinity Chromatography using the immunizing peptide Buffer System: Tris saline, pH~7.3 Preservatives: 0.02% Sodium Azide Stabilizers: 0.5% BSA Applications: Peptide ELISA: 1/8000 (Detection Limit). Western blot: 0.01-0.03 mg/ml. Approx 24kDa band observed in Human Placenta lysates (calculated MW of 22.6kDa according to NP_003177.2). Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
    [Show full text]
  • Transcriptomic Landscape of Early Age Onset of Colorectal Cancer Identifies
    www.nature.com/scientificreports OPEN Transcriptomic landscape of early age onset of colorectal cancer identifes novel genes and pathways in Indian CRC patients Manish Pratap Singh, Sandhya Rai, Nand K. Singh & Sameer Srivastava* Past decades of the current millennium have witnessed an unprecedented rise in Early age Onset of Colo Rectal Cancer (EOCRC) cases in India as well as across the globe. Unfortunately, EOCRCs are diagnosed at a more advanced stage of cancer. Moreover, the aetiology of EOCRC is not fully explored and still remains obscure. This study is aimed towards the identifcation of genes and pathways implicated in the EOCRC. In the present study, we performed high throughput RNA sequencing of colorectal tumor tissues for four EOCRC (median age 43.5 years) samples with adjacent mucosa and performed subsequent bioinformatics analysis to identify novel deregulated pathways and genes. Our integrated analysis identifes 17 hub genes (INSR, TNS1, IL1RAP, CD22, FCRLA, CXCL3, HGF, MS4A1, CD79B, CXCR2, IL1A, PTPN11, IRS1, IL1B, MET, TCL1A, and IL1R1). Pathway analysis of identifed genes revealed that they were involved in the MAPK signaling pathway, hematopoietic cell lineage, cytokine–cytokine receptor pathway and PI3K-Akt signaling pathway. Survival and stage plot analysis identifed four genes CXCL3, IL1B, MET and TNS1 genes (p = 0.015, 0.038, 0.049 and 0.011 respectively), signifcantly associated with overall survival. Further, diferential expression of TNS1 and MET were confrmed on the validation cohort of the 5 EOCRCs (median age < 50 years and sporadic origin). This is the frst approach to fnd early age onset biomarkers in Indian CRC patients.
    [Show full text]